Method of treating skin wounds with vectors encoding hepatocyte growth factor
AssigneeAnGes MG, Inc.
InventorsRyuichi Morishita, Kuniaki Nakanishi, Yasufumi Kaneda, Hitoshi Kotani
Life of this patent
Estimating the term…
Abstract
The present invention relates to a therapeutic preventive agent that includes an angiogenic factor gene (such as hepatocyte growth factor (HGF), vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), and hypoxia inducible factor (HIF)) as its active ingredient, and the administration of such an agent into the targeted skin diseases-affected area.
Claims7
A method for accelerating the initial stage of skin wound healing, comprising direct administration of a plasmid or viral vector encoding a full length hepatocyte growth factor (HGF) to the wound, wherein the HGF is expressed, thereby accelerating the initial stage of skin wound healing.
Dependencies are inferred from the claim text.